EXTON, PA -- (MARKET WIRE) -- April 23, 2007 -- Rheologics Technologies Inc. (“Rheologics” or the “Company”) (PINKSHEETS: RTGI), the leader in the study of blood viscosity and its relationship to cardiovascular disease, announces plans for a multi-center clinical study on the variability of whole blood viscosity.
